Alumis

Alumis Intangible Assets

Intangible Assets of Alumis (ALMS) as of Oct 17, 2026.

Intangible Assets

-USD

Last updated:

Intangible Assets of Alumis is 2026 - USD. Intangible Assets of Alumis was 2025 - USD. It decreases by % lower compared to the previous year.

The Alumis Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
The Alumis Intangible Assets history
YEARIntangible AssetsYoY
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alumis Stock analysis

What does Alumis do? Alumis Inc, headquartered in South San Francisco, California, is a clinical-stage biopharmaceutical company operating in the Pharmaceuticals sector. The company develops TYK2 inhibitors ESK-001 for plaque psoriasis, lupus, and uveitis, and A-005 for neuroinflammatory and neurodegenerative diseases. With 221 employees, Alumis focuses on immune-mediated diseases through monotherapy and combination therapies, leveraging data analytics to identify potential treatment targets. Alumis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alumis stock

On Eulerpool you can find the complete historical development of Intangible Assets Alumis since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Alumis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Alumis

All Key Metrics — Alumis